相关实验视频
Updated: Jun 11, 2025

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
9.5K
开发基于四基诺林的慢性疼痛抑制剂
Ketul V Patel1,2, Vinicius M Gadotti3,4,5, Agustin Garcia-Caballero3,4,5
1Department of Chemistry, University of Calgary, Calgary T2N 1N4, Alberta, Canada.
ACS chemical neuroscience
|October 8, 2024
概括
研究人员开发了针对Cav3.2-USP5相互作用的新型小分子,以缓解慢性疼痛. 这些化合物在临床前模型中显示出有效性,为疼痛管理提供了一个有希望的新治疗策略.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 疼痛研究和治疗方法
背景情况:
- 慢性疼痛是一个广泛的健康问题,现有的治疗方法不足.
- 新的治疗策略对于有效的慢性疼痛管理至关重要.
- Cav3.2通道及其与USP5的相互作用与疼痛通路有关.
研究的目的:
- 识别和开发抑制Cav3.2-USP5相互作用的小分子.
- 在临床前疼痛模型中评估这些分子的治疗潜力.
主要方法:
- 一个四化素 (THQ) 支架的结构-活性关系研究.
- 在体外测试以评估Cav3.2-USP5相互作用的抑制.
- 对急性和慢性疼痛的小鼠模型的药理动力学评估和体内研究.
- 使用Cav3.2无效小鼠进行验证,以确认作用模式.
主要成果:
- 确定了一种强烈抑制Cav3.2-USP5相互作用的分子家族.
- 化合物在体外表现出有利的药理动力学特性和体内有效性.
- 小分子在急性和慢性疼痛的小鼠模型中表现出有效性.
- 在无效小鼠中证实了Cav3.2通道依赖性,支持了作用机制.
结论:
- 破坏Cav3.2-USP5相互作用是慢性疼痛管理的可行策略.
- 鉴定到的小分子代表了一类新的潜在治疗疼痛的新疗法.
- 这些化合物需要进一步开发,以便在慢性疼痛治疗中临床应用.
相关概念视频
Analgesia and Pain Management
547
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
547
Opioid Analgesics: Synthetic and Semisynthetic Opioids
239
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
239
Opioid Analgesics: Morphine and Other Natural Cogeners
190
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
190
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
542
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
542
Opioid Receptors: Overview
564
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
564

